Publications by authors named "Jingli Gu"

Claim this Profile
M
MASS-4 is more suitable than MASS-3 for prognostic stratification in transplant-eligible patients with newly diagnosed multiple myeloma.
Fan Yang, Junru Liu, Jingli Gu, Meilan Chen, Beihui Huang

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of early minimal residual disease assessment on the outcomes of patients with systemic light chain amyloidosis.
Xiaozhe Li, Meilan Chen, Junru Liu, Jingli Gu, Beihui Huang

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving treatments and outcomes in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a real-world study in China.
Li Xiaozhe, Chen Meilan, Liu Junru, Gu Jingli, Huang Beihui

BMC Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Feature and Predictive Model for Transplanted Patients With Functional High-Risk Multiple Myeloma.
Tongyong Yu, Meilan Chen, Beihui Huang, Junru Liu, Xiaozhe Li, Jingli Gu

Arch Med Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and risk factors of infection in initially treated patients with multiple myeloma during the induction period.
Qianying Pan, Beihui Huang, Junru Liu, Meilan Chen, Jingli Gu

J Infect Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Identification of the Non-Transplanted Functional High-Risk Multiple Myeloma: Insights from a Predictive Nomogram.
Yanjuan Li, Lifen Kuang, Beihui Huang, Junru Liu, Meilan Chen, Jingli Gu

Biomedicines· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The characteristics of patients with multiple myeloma surviving over 10 years.
Beihui Huang, Hongning Zhang, Junru Liu, Jingli Gu, Meilan Chen

Front Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The identification and correction of pseudohypercalcemia.
Tongyong Yu, Xiaozhe Li, Beihui Huang, Jingli Gu, Junru Liu

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum and Urine Metabolic Fingerprints Characterize Renal Cell Carcinoma for Classification, Early Diagnosis, and Prognosis.
Xiaoyu Xu, Yuzheng Fang, Qirui Wang, Shuanfeng Zhai, Wanshan Liu, Jingli Gu

Adv Sci (Weinh)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization.
Li-Qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang

Ann Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma.
Huihui Zhu, Junru Liu, Jingli Gu, Meilan Chen, Lifen Kuang

Br J Haematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost.
Li-Qiong Hou, Jun-Ru Liu, Jing-Li Gu, Mei-Lan Chen, Li-Fen Kuang

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience.
Yanjuan Li, Junru Liu, Beihui Huang, Meilan Chen, Jingli Gu

Ann Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.
Beihui Huang, Huixin Liu, Szehoi Chan, Junru Liu, Jingli Gu

Med Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance.
Junru Liu, Beihui Huang, Jingli Gu, Juan Li

J Pers Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score.
Yadong Chen, Jingli Gu, Beihui Huang, Junru Liu, Xiaozhe Li

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study.
Li Xiaozhe, Chen Meilan, Huang Beihui, Liu Junru, Gu Jingli

Integr Cancer Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT.
Qian Sun, Xiaozhe Li, Jingli Gu, Beihui Huang, Junru Liu

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical value of minimal residual disease assessed by multiparameter flow cytometry in amyloid light chain amyloidosis.
Xiaozhe Li, Beihui Huang, Junru Liu, Meilan Chen, Jingli Gu

J Cancer Res Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Jingli Gu, Junru Liu, Xiaozhe Li, Waiyi Zou, Beihui Huang

Cancer Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of the management of mental well-being and empathy in Chinese medical students: a randomized controlled study.
Rong Rong, Wei Chen, Zihao Dai, Jingli Gu, Weiying Chen

BMC Med Educ· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of efficacy, safety, patients' quality of life, and doctors' occupational stress between lenalidomide-based and bortezomib-based induction in patients with newly diagnosed multiple myeloma.
Limei Xu, Junru Liu, Beihui Huang, Lifen Kuang, Jingli Gu

Cancer Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life of patients with multiple myeloma: A real-world study in China.
Xiaozhe Li, Junru Liu, Meilan Chen, Jingli Gu, Beihui Huang

Cancer Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma.
Limei Xu, Junru Liu, Meilan Chen, Lifen Kuang, Beihui Huang, Jingli Gu

Ann Hematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal Microbiota Taxonomic Shifts in Chinese Multiple Myeloma Patients Analyzed by Quantitative Polimerase Chain Reaction (QPCR) and 16S rRNA High-Throughput Sequencing.
Bingqing Zhang, Jingli Gu, Junru Liu, Beihui Huang, Juan Li

Med Sci Monit· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis